Discovery MI Gen2 vs Volta AF-Xplorer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Discovery MI Gen2

by GE HealthCare

Volta AF-Xplorer

by Volta Medical

AI Verdict

Discovery MI Gen2 is a diagnostic PET/CT imaging system leveraging AI for oncology, neurology, and cardiology, providing detailed anatomical and metabolic information. In contrast, Volta AF-Xplorer is an AI-assisted software solution designed for real-time guidance during electrophysiology ablation procedures for complex atrial fibrillation. While both utilize AI in cardiology, they serve distinct purposes: diagnosis and staging versus interventional procedural support.

Choose Discovery MI Gen2 if…

Choose Discovery MI Gen2 if your primary need is advanced, high-precision diagnostic imaging across oncology, neurology, and cardiology. This system is ideal for facilities seeking superior small lesion detectability, accurate quantitative measurements, and reduced patient dose and scan times through deep-learning AI and motion correction technologies.

View Discovery MI Gen2 →

Choose Volta AF-Xplorer if…

Choose Volta AF-Xplorer if your electrophysiology lab requires real-time, AI-assisted guidance during complex atrial fibrillation and atrial tachycardia ablation procedures. This tool is best suited for clinicians aiming to precisely identify and target dispersed electrograms to improve treatment outcomes for challenging arrhythmias.

View Volta AF-Xplorer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Discovery MI Gen2	Volta AF-Xplorer
Pricing	Contact vendor for pricing	Contact for pricing
Deployment	On-premise (physical hardware)	Software, integrated with existing electrophysiology lab hardware (e.g., EP recording systems, 3D navigation systems, mapping catheters).
FDA Status	Cleared AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools offer significant usability enhancements in their respective contexts. Discovery MI Gen2 streamlines imaging acquisition with automated patient positioning and reduced scan times, while Volta AF-Xplorer simplifies complex real-time procedural guidance with a 'Simple User Interface' and automated tagging of regions of interest. Each aims to reduce complexity and improve efficiency for its users within their specialized domains.

Clinical Value

Discovery MI Gen2

Discovery MI Gen2 offers superior diagnostic imaging across multiple major disease areas, including oncology, neurology, and cardiology, with quantifiable improvements like up to 41% increased small lesion detectability. While Volta AF-Xplorer provides high clinical value by guiding complex electrophysiology ablation procedures, Tool A's broader impact and specific metrics for diagnostic enhancement give it an edge in overall clinical value.

Pricing & Value

Tie

Discovery MI Gen2 has a disclosed ultra-premium price range of $950,000-$1,900,000 for refurbished systems, representing a significant capital investment. Volta AF-Xplorer's pricing is not publicly disclosed, making a direct comparison of cost-effectiveness or overall value impossible. Without specific pricing for Tool B, a definitive winner cannot be determined.

Enterprise Readiness

Discovery MI Gen2

GE HealthCare, the manufacturer of Discovery MI Gen2, is a global leader in medical technology with extensive infrastructure and a long history of supporting large-scale medical equipment in healthcare enterprises. While Volta AF-Xplorer explicitly confirms HIPAA compliance and BAA, GE HealthCare's established reputation, global reach, and comprehensive support for capital equipment inherently provide a more robust enterprise readiness profile.

Innovation

Tie

Both tools demonstrate significant innovation in their respective fields. Discovery MI Gen2 integrates deep-learning AI for advanced image reconstruction and motion management in PET/CT, pushing diagnostic imaging boundaries. Volta AF-Xplorer applies real-time AI for decision support during complex electrophysiology ablation procedures, representing a novel application of AI for interventional guidance.

Support & Docs

Discovery MI Gen2

Neither tool's provided facts explicitly detail support or documentation. However, GE HealthCare, as a major global medical device manufacturer, is renowned for its comprehensive support infrastructure, extensive documentation, and training programs for its high-value capital equipment. This level of support is likely more robust and globally available than what a smaller, specialized company like Volta Medical typically offers.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Discovery MI Gen2	Volta AF-Xplorer
Product Name	Discovery MI Gen2	Volta AF-Xplorer
Company	GE HealthCare	Volta Medical
Primary Application	Next-generation digital PET/CT system for diagnostic imaging in oncology, neurology, and cardiology.	AI-assisted mapping and decision-support system for electrophysiology ablation procedures, detecting dispersed electrograms in real-time.
Key AI Functionality	Deep-learning based image reconstruction (TrueFidelityu2122), MotionFree digital respiratory motion management.	Real-time detection and annotation of dispersed electrograms (EGMs), automated tagging of regions of interest.
Target Medical Specialties	Nuclear Medicine, Oncology, Radiology	Cardiology

Videos

Demos, reviews, and walkthroughs featuring Discovery MI Gen2 and Volta AF-Xplorer.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools address different clinical needs within cardiology, and for which specific patient populations are they best suited?

Discovery MI Gen2 is a diagnostic PET/CT system primarily used for imaging in oncology, neurology, and general cardiology, focusing on high-resolution scans and small lesion detectability. Volta AF-Xplorer is an AI-assisted mapping and decision-support system specifically designed for electrophysiology ablation procedures, guiding treatment for complex atrial fibrillation and atrial tachycardia.

What is the expected workflow integration for each tool within existing clinical environments, and how deep is their EHR integration?

Discovery MI Gen2 integrates into radiology and nuclear medicine workflows, acquiring images that would typically be managed through PACS and subsequently linked to EHRs. Volta AF-Xplorer integrates directly into the electrophysiology lab, providing real-time data and decision support during ablation procedures and is compatible with most EP recording and 3D navigation systems, including potential for automated tagging with systems like EnSite X.

What specific metrics or features demonstrate the accuracy and sensitivity of each tool in its respective clinical application?

Discovery MI Gen2 offers up to a 125% increase in sensitivity and up to a 41% increase in small lesion detectability, alongside Q.Clear quantitation for accurate SUV measurements. Volta AF-Xplorer provides real-time detection and annotation of dispersed electrograms, a Dispersion Indicator with color-coded levels, and a Booster Mode to increase software sensitivity during atrial tachycardia or slow atrial fibrillation.

What is the anticipated learning curve for physicians and technologists to become proficient with each system, especially considering their AI-driven features?

Discovery MI Gen2 features automated patient positioning (Auto IN) and deep-learning based image reconstruction (TrueFidelityu2122), which aim to streamline the technologist experience and potentially reduce the learning curve for image acquisition and quality. Volta AF-Xplorer is designed with a simple user interface for real-time identification of regions of interest and is compatible with existing EP lab setups, suggesting a tailored and intuitive workflow for electrophysiologists.

What are the key considerations for a multi-site rollout of each tool, and how do they differ in terms of implementation complexity?

Implementing Discovery MI Gen2 across multiple sites would involve significant logistical planning for physical hardware installation, calibration, and staff training at each location. Volta AF-Xplorer, being software-based and compatible with most existing EP lab hardware, may offer a more streamlined multi-site rollout primarily focused on software deployment, integration, and user training.

Beyond HIPAA, what advanced security features or audit-trail capabilities do these tools offer to ensure data integrity and accountability?

While both companies emphasize HIPAA compliance, specific advanced security features beyond this, such as detailed audit-trail functionalities for user actions or data access, would require direct inquiry with each vendor. GE HealthCare generally employs a multi-layer strategic approach to cybersecurity for its devices, including automated OS patches and software updates, and offers ongoing cybersecurity protection through its Continuityu2122 service.

What is the typical time-to-value for each system, and are customer references or clinical trial data available to demonstrate real-world impact?

The time-to-value for Discovery MI Gen2 would involve installation, training, and integration into imaging schedules, with GE HealthCare typically providing customer experiences. Volta AF-Xplorer has demonstrated clinical outcomes in studies like TAILORED-AF and RESTART, showing improved freedom from AF at 12 months and real-world use at multiple centers, which can help demonstrate its value.